Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Marker Therapeutics, Inc. | tm205467d1_ex32-2.htm |
EX-31.2 - EXHIBIT 31.2 - Marker Therapeutics, Inc. | tm205467d1_ex31-2.htm |
EX-32.1 - EXHIBIT 32.1 - Marker Therapeutics, Inc. | tm205467d1_ex32-1.htm |
EX-31.1 - EXHIBIT 31.1 - Marker Therapeutics, Inc. | tm205467d1_ex31-1.htm |
EX-23.1 - EXHIBIT 23.1 - Marker Therapeutics, Inc. | tm205467d1_ex23-1.htm |
EX-4.25 - EXHIBIT 4.25 - Marker Therapeutics, Inc. | tm205467d1_ex4-25.htm |
10-K - FORM 10-K - Marker Therapeutics, Inc. | tm205467-1_10k.htm |
Exhibit 21.1
SUBSIDIARIES
Marker Cell Therapy, Inc.
GeneMax Pharmaceuticals, Inc.
GeneMax Pharmaceuticals Canada, Inc.